Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES discuss recent advances in diabetes technology and their impact on patient care.
October 29th 2021
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide an overview of the pillars of technology utilized in diabetes care: Continuous glucose monitors (CGMs), smart insulin pumps, and connected insulin pens.
Experts in diabetes discuss recent advances in insulin pen technology, including connected and smart pens, and their impact on diabetes care.
Robert Busch, MD, and Diana Issacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into the use of insulin pumps in type 2 diabetes and describe currently available smart pumps.
A panel of experts discuss the impact of continuous glucose monitoring (CGM) on individualized patient care plans for patients with type 1 and type 2 diabetes.
Robert Busch, MD, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discuss metrics to evaluate diabetes control, including time in range and coefficient of variation.
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; Robert Busch, MD; and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, provide insight into quality-of-life improvements that have followed advances in diabetes technology and review available continuous glucose monitors.
Experts in diabetes discuss the transition to telemedicine during the COVID-19 pandemic and its impact on diabetes care.
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, presents a case study of a patient with type 2 diabetes mellitus, an insulin pump, and a continuous glucose monitor.